Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
K Farsalinos, A Barbouni, R Niaura - Internal and emergency medicine, 2020 - Springer
The effects of smoking on Corona Virus Disease 2019 (COVID-19) are currently unknown.
The purpose of this study was to systematically examine the prevalence of current smoking …
The purpose of this study was to systematically examine the prevalence of current smoking …
Mild cognitive impairment in clinical practice: a review article
S Jongsiriyanyong… - American Journal of …, 2018 - journals.sagepub.com
The spectrum of cognitive decline in the elderly ranges from what can be classified as
normal cognitive decline with aging to subjective cognitive impairment to mild cognitive …
normal cognitive decline with aging to subjective cognitive impairment to mild cognitive …
[HTML][HTML] Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
K Farsalinos, R Niaura, J Le Houezec, A Barbouni… - Toxicology reports, 2020 - Elsevier
As of 20 April, almost 1.7 million people globally have been diagnosed with Corona Virus
Disease 2019 (COVID-19), a pandemic that has evolved from the emergence of a new …
Disease 2019 (COVID-19), a pandemic that has evolved from the emergence of a new …
Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
K Farsalinos, A Barbouni, K Poulas… - … advances in chronic …, 2020 - journals.sagepub.com
Background: The purpose of this study was to examine the prevalence and effects of current
smoking on adverse outcomes among hospitalized COVID-19 patients. Methods: A …
smoking on adverse outcomes among hospitalized COVID-19 patients. Methods: A …
Network-based in silico drug efficacy screening
The increasing cost of drug development together with a significant drop in the number of
new drug approvals raises the need for innovative approaches for target identification and …
new drug approvals raises the need for innovative approaches for target identification and …
Effects of virtual reality intervention on cognition and motor function in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis
S Zhu, Y Sui, Y Shen, Y Zhu, N Ali, C Guo… - Frontiers in aging …, 2021 - frontiersin.org
Background: Virtual reality (VR) intervention is an innovative and efficient rehabilitative tool
for patients affected by stroke, Parkinson's disease, and other neurological disorders. This …
for patients affected by stroke, Parkinson's disease, and other neurological disorders. This …
Nicotinic cholinergic system and COVID-19: in silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting …
While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell
entry, it is important to examine other potential interactions between the virus and other cell …
entry, it is important to examine other potential interactions between the virus and other cell …
Preventing dementia? Interventional approaches in mild cognitive impairment
V Lissek, B Suchan - Neuroscience & Biobehavioral Reviews, 2021 - Elsevier
Mild cognitive impairment (MCI) is defined as an intermediate state between normal
cognitive aging and dementia. It describes a status of the subjective impression of cognitive …
cognitive aging and dementia. It describes a status of the subjective impression of cognitive …
Treatment for mild cognitive impairment: systematic review
Background More people are presenting with mild cognitive impairment (MCI), frequently a
precursor to dementia, but we do not know how to reduce deterioration. Aims To …
precursor to dementia, but we do not know how to reduce deterioration. Aims To …
APOE genotype and Alzheimer's disease: the influence of lifestyle and environmental factors
E Angelopoulou, YN Paudel… - ACS chemical …, 2021 - ACS Publications
Alzheimer's disease (AD) is the most common neurodegenerative disorder with obscure
pathogenesis and no disease-modifying therapy to date. AD is multifactorial disease that …
pathogenesis and no disease-modifying therapy to date. AD is multifactorial disease that …